Have you heard? We have changed name. Find out more now!
Latest News
TGA review: Gadolinium-based contrast agents for MRI scans
Posted 31st July 2017

The TGA has reviewed recent information relating to the potential for small amounts of gadolinium to be retained in the brain, following use of gadolinium-based contrast agents during magnetic resonance imaging (MRI) scans.

No harmful effects of gadolinium retention in the brain have been identified at this time, but the TGA is working with sponsors of these products to update their Product Information (PI) documents to reflect the new information.

Gadolinium-based contrast agents are injected into a patient's vein to enhance the quality of MRI scans of internal organs, blood vessels and tissues. MRI scans help health professionals to diagnose medical conditions. There are two types of gadolinium-based contrast agents - linear agents and macrocyclic agents.

Published studies have found that linear gadolinium-based contrast agents appear to result in greater gadolinium retention in the brain than macrocyclic agents (see below for references). The TGA will continue to monitor this issue and take further action if necessary.

Read Full article here.


Improving patient safety an important motivation for personal development
Posted 27th July 2017
  Patrick Eastgate 

Our very own President Patrick Eastgate was recently profiled in the MRPBA newsletter discussing the scope of practice for radiographers and pushing the boundaries towards advanced practice. 

Read article here.